Lactofiltrum

Developed for: bacterial vaginosis
Investigated by: Avva Rus, JSC · Kirov Regional clinical Center of Perinatology · Kirov State Medical Academy

today NCT01089348 · Ph 2/3

20112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2/3	NCT01089348	Jul → Oct 2010	bacterial vaginosis	Avva Rus, JSC	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Lactofiltrum	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01089348 ↗
Route	Oral	“Lactofiltrum (orally administered tablets)” NCT01089348 ↗